Department of Anesthesiology, Emergency and Intensive Care Medicine, University of Göttingen, Göttingen, Germany.
Department of Experimental Animal Medicine, University of Göttingen, Göttingen, Germany.
Crit Care Med. 2019 Jan;47(1):33-40. doi: 10.1097/CCM.0000000000003430.
Minimally invasive extracorporeal CO2 removal is an accepted supportive treatment in chronic obstructive pulmonary disease patients. Conversely, the potential of such technique in treating acute respiratory distress syndrome patients remains to be investigated. The aim of this study was: 1) to quantify membrane lung CO2 removal (VCO2ML) under different conditions and 2) to quantify the natural lung CO2 removal (VCO2NL) and to what extent mechanical ventilation can be reduced while maintaining total expired CO2 (VCO2tot = VCO2ML + VCO2NL) and arterial PCO2 constant.
Experimental animal study.
Department of Experimental Animal Medicine, University of Göttingen, Germany.
Eight healthy pigs (57.7 ± 5 kg).
The animals were sedated, ventilated, and connected to the artificial lung system (surface 1.8 m, polymethylpentene membrane, filling volume 125 mL) through a 13F catheter. VCO2ML was measured under different combinations of inflow PCO2 (38.9 ± 3.3, 65 ± 5.7, and 89.9 ± 12.9 mm Hg), extracorporeal blood flow (100, 200, 300, and 400 mL/min), and gas flow (4, 6, and 12 L/min). At each setting, we measured VCO2ML, VCO2NL, lung mechanics, and blood gases.
VCO2ML increased linearly with extracorporeal blood flow and inflow PCO2 but was not affected by gas flow. The outflow PCO2 was similar regardless of inflow PCO2 and extracorporeal blood flow, suggesting that VCO2ML was maximally exploited in each experimental condition. Mechanical ventilation could be reduced by up to 80-90% while maintaining a constant PaCO2.
Minimally invasive extracorporeal CO2 removal removes a relevant amount of CO2 thus allowing mechanical ventilation to be significantly reduced depending on extracorporeal blood flow and inflow PCO2. Extracorporeal CO2 removal may provide the physiologic prerequisites for controlling ventilator-induced lung injury.
微创体外 CO2 去除术是慢性阻塞性肺疾病患者的一种公认的支持性治疗方法。相反,该技术在治疗急性呼吸窘迫综合征患者中的潜力仍有待研究。本研究的目的是:1)量化不同条件下膜肺 CO2 去除(VCO2ML),2)量化自然肺 CO2 去除(VCO2NL)以及在维持总呼气 CO2(VCO2tot = VCO2ML + VCO2NL)和动脉 PCO2 不变的情况下,机械通气可以减少多少。
实验动物研究。
德国哥廷根大学实验动物医学系。
8 只健康猪(57.7 ± 5 kg)。
动物被镇静、通气并通过 13F 导管连接到人工肺系统(表面积 1.8 m,聚甲基戊烯膜,填充体积 125 mL)。在不同的 inflow PCO2(38.9 ± 3.3、65 ± 5.7 和 89.9 ± 12.9 mm Hg)、体外血流(100、200、300 和 400 mL/min)和气体流量(4、6 和 12 L/min)组合下测量 VCO2ML。在每种设置下,我们测量了 VCO2ML、VCO2NL、肺力学和血气。
VCO2ML 随体外血流和 inflow PCO2 呈线性增加,但不受气体流量影响。无论 inflow PCO2 和体外血流如何,流出 PCO2 相似,这表明在每种实验条件下,VCO2ML 都得到了最大程度的利用。在维持 PaCO2 不变的情况下,机械通气可以减少 80-90%。
微创体外 CO2 去除去除了大量的 CO2,因此可以根据体外血流和 inflow PCO2 显著减少机械通气。体外 CO2 去除可能为控制呼吸机诱导性肺损伤提供生理前提。